Name and Position

Matthew Roe


Matthew Roe retired in 2017 after 35 years in biotechnology and life-science developing medicines to treat brain cancer, Alzheimer’s and psoriasis. Most recently he was Head of Product Marketing at Abcam in Cambridge, the world’s largest provider of antibodies for research. He was a trustee for his company pension scheme and two biotechnology advisory boards.